Novo Nordisk earnings: sales of weight-loss drug Wegovy lower than expected

CGTN Europe 2024-08-07

Views 434

Soeren Loentoft Hansen, Senior Equity Analyst at Sydbank, speaks to CGTN Europe about the contributing factors.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Weight Loss Bubble? Investors Bullish on Novo Nordisk and Eli Lilly as Obesity Epidemic Drives Sales of Ozempic and Wegovy
play
00:42

Weight Loss Bubble? Investors Bullish on Novo Nordisk and Eli Lilly as Obesity Epidemic Drives Sales of Ozempic and Wegovy
Two thirds of Samsung's affiliates post lower than expected earnings
play
00:32

Two thirds of Samsung's affiliates post lower than expected earnings
Sime Darby's FY15 earnings expected to be lower
play
01:37

Sime Darby's FY15 earnings expected to be lower
Two thirds of Samsung's affiliates post lower than expected earnings
play
00:34

Two thirds of Samsung's affiliates post lower than expected earnings
Sime Darby's FY15 earnings expected to be lower
play
01:37

Sime Darby's FY15 earnings expected to be lower
Samsung Electronics' 2018 Q4 earnings lower than expected
play
02:42

Samsung Electronics' 2018 Q4 earnings lower than expected
iPhone Sales Drive Apple's Better-than-Expected Q2 Earnings
play
00:46

iPhone Sales Drive Apple's Better-than-Expected Q2 Earnings
Ulta Beauty Q3 Earnings Highlights: Shares Are Trading Higher After The Company Reported Better-Than-Expected Q3 Sales Results And Revised FY23 Guidance
play
01:52

Ulta Beauty Q3 Earnings Highlights: Shares Are Trading Higher After The Company Reported Better-Than-Expected Q3 Sales Results And Revised FY23 Guidance
Apple iPhone 16 sales lower than expected
play
02:00

Apple iPhone 16 sales lower than expected
Novo Nordisk to Invest $4.1 Billion in New North Carolina Plant for Wegovy and Ozempic Production
play
00:49

Novo Nordisk to Invest $4.1 Billion in New North Carolina Plant for Wegovy and Ozempic Production
Wegovy heart benefits due to more than weight loss -Novo Nordisk
play
01:32

Wegovy heart benefits due to more than weight loss -Novo Nordisk
'Stop Ripping Us Off.' Senate Grills Novo Nordisk on High Prices of Weight Loss Drugs Wegovy and Ozempic in US.
play
00:38

'Stop Ripping Us Off.' Senate Grills Novo Nordisk on High Prices of Weight Loss Drugs Wegovy and Ozempic in US.